Workflow
央行调整14天期逆回购操作规则
中国证券报· 2025-09-20 04:18
(上接A01版)公开市场7天期逆回购操作利率的政策地位得以明确。但14天期逆回购操作利率长期以 来是7天期加15BP,也被市场参与者认为具有一定政策属性。 ● 本报记者 彭扬 9月19日,中国人民银行发布公告称,为保持银行体系流动性充裕,更好满足不同参与机构差异化资金 需求,即日起,公开市场14天期逆回购操作调整为固定数量、利率招标、多重价位中标,操作时间和规 模将根据流动性管理需要确定。 "启动14天期逆回购操作提前投放跨节资金,展现适度宽松的货币政策取向。"业内专家表示,近年来央 行通常在"十一"和春节长假前启动14天期逆回购操作,启动时间根据节假日安排和机构需求灵活调整, 以提前为机构提供跨节资金,保持流动性充裕。 本次14天期逆回购操作的启动时点略早于往年,使得实际占款日达到17天。叠加前期央行已经通过买断 式逆回购净投放了3000亿元资金,这有利于进一步缓解季末、长假前机构的预防性资金需求,保障跨 季、跨节资金面平稳。 从招标方式看,此次公告称,14天期逆回购采用美式招标,进一步强化了7天期逆回购操作利率的政策 地位。梳理近期央行工作可以发现,这是强化7天期逆回购政策利率地位的又一举措。 上述专家表 ...
TexCap Conference Brings Together Leaders from 3 Major US Stock Exchanges to Offer Insights into Burgeoning Texas Capital Markets Hub
Newsfile· 2025-09-20 04:18
TexCap Conference Brings Together Leaders from 3 Major US Stock Exchanges to Offer Insights into Burgeoning Texas Capital Markets HubOne-day educational event offers opportunities to learn from innovators driving financial transformation and network with key players shaping the future of financeSeptember 19, 2025 4:18 PM EDT | Source: Texas Blockchain CouncilDallas, Texas--(Newsfile Corp. - September 19, 2025) - A bull market is coming to Texas, and the inaugural TexCap capital markets confere ...
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
Globenewswire· 2025-09-20 04:18
CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide for patients with chronic hypoparathyroidism (HP) and host an investor webcast on Monday, September 22. The Company will host ...
Darden Restaurants: A Textbook Buy-the-Dip Opportunity
MarketBeat· 2025-09-20 04:16
Darden Restaurants TodayDRIDarden Restaurants$184.83 -7.91 (-4.10%) 52-Week Range$155.18▼$228.27Dividend Yield3.25%P/E Ratio20.81Price Target$224.21Add to WatchlistThe only thing wrong with Darden Restaurants' NYSE: DRI Q1 earnings report is that it wasn’t better than expected. Other than that single flaw, all other details are bullish and affirm an outlook for rising share prices. The takeaway is that the 10% share price reduction is a knee-jerk reaction to the news and an otherwise opportunistic entry po ...
The Artificial Intelligence Bubble: Sam Altman’s Stark Warning
Medium· 2025-09-20 04:16
The Artificial Intelligence Bubble: Sam Altman’s Stark WarningAs startups chase sky-high valuations and corporations struggle to integrate AI, the OpenAI chief admits the industry may be headed for a dot-com-style reckoning.LEROBITcast4 min read·Just nowJust now--Press enter or click to view image in full sizeimagem gerada através de IA.“Are we in a phase where investors as a whole are overexcited about AI? My opinion is yes.” — Sam Altman, CEO da OpenAI.A última declaração de Sam Altman que mais se espalho ...
MGV: Low-Cost Large-Cap Value Has Its Place In A Portfolio
Seeking Alpha· 2025-09-20 04:16
Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry experience. Prior to working in the investment management industry, Michael spent over a decade in professional services working across industries that include O&G, OFS, Midstream, Industrials, Information Technology, EPC Services, and consumer discretionary.Investment recommendations are built upon the entirety of the investment ecosystem rather than considering a company independently.Analys ...
New Apple iPhone 17 goes on sale worldwide
Fox Business· 2025-09-20 04:15
Apple's new iPhone 17 hit store shelves worldwide on Friday, with customers flocking to locations vying to get the latest device. Apple's new thinner smartphone offering is known as the iPhone Air and will be in the middle of the company's iPhone lineup between less expensive iPhone 17 models and more expensive iPhone 17 Pro models. The iPhone 17 will be $799, while the iPhone Air will cost $999 and the iPhone 17 Pro will total $1,099.The company said the iPhone Air is its thinnest iPhone ever, and it's onl ...
海外存储巨头集体涨价 国内厂商迎来机遇
中国经营报· 2025-09-20 04:15
存储芯片价格上涨趋势 - 闪迪宣布所有渠道和消费者客户产品价格调涨超10% [2] - 美光通知渠道存储产品上涨20%-30%并暂停所有DDR4/DDR5/LPDDR4/LPDDR5产品报价一周 [2] - 西部数据宣布立即逐步提高所有硬盘产品价格 [2] - 闪存市场数据显示1Tb QLC/1Tb TLC/512Gb TLC NAND Flash Wafer价格分别调涨2.1%/1.9%/3.2%至4.90/5.50/3.20美元 [4] - DDR5 16Gb/24Gb颗粒价格分别调整至5.05/7.95美元 [4] 涨价驱动因素 - 北美大型云服务提供商持续加大服务器建设投入推动存储芯片强劲采购需求 [2] - 人工智能应用及数据中心/客户端/移动领域存储需求驱动 [3] - 产品组合各容量需求空前旺盛 [3] - 供不应求市场环境下NAND Flash率先涨价 DRAM供应商跟进暂停报价 [2] - 原厂需评估需求量能并规划未来产能 [2] 市场供需状况 - 渠道市场客户询单明显增加 NAND资源供应有限 [5] - 渠道SSD成品出现缺货现象 厂商全面调涨SSD价格 [5] - DDR4资源市场流通受阻供应较少 DDR5资源供应有限价格持续上扬 [5] - 供给方具报价优势 合约价延续上涨动能 [5] - 模组厂可随行就市将上游涨幅传导至终端 [6] 产业链公司影响 - A股存储产业链公司股价普遍上涨 香农芯创涨超80% 协创数据涨超60% 德明利涨近40% [7] - 群联因股价涨幅过大被要求公布单月损益 [6] - 佰维存储表示产品随行就市 根据市场情况调整价格 [7] - 德明利指出第二季度经营业绩环比改善 行业景气度有望延续 [7] - 国产存储厂商性价比提升 可能获得更多市场份额 [8] 行业前景展望 - 闪存价格开启更广泛上涨趋势且具备延续性 [7] - 前四大NAND生产商有望跟进调价 [7] - 消费类市场产品将立竿见影 To B市场新订单将实现价格传递 [8] - 明年NAND Flash预计仍会缺货 但希望价格温和上涨 [6] - 国产替代进程可能加速 [8]
Bank of America Declares Preferred Stock Dividends Payable in October and November 2025
Prnewswire· 2025-09-20 04:15
CHARLOTTE, N.C. , Sept. 19, 2025 /PRNewswire/ -- Bank of America Corporation today announced the Board of Directors has authorized regular cash dividends on the outstanding shares or depositary shares of the following series of preferred stock: Series of Preferred Stock Dividend per Shareor Depositary Share 1 Record Date Payment Date 7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L $18.1250000 October 1 October 30 5.875% Non-Cumulative Preferred Stock, Series HH $0.3671875 October 1 Oc ...
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
Globenewswire· 2025-09-20 04:15
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has filed an amended and restated preliminary short form base shelf prospectus (the “Prospectus”) to provide the Company with the flexibility to take advantage of financing opportunities and favourable market con ...